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The present studies explore the role of polymicrobial infection in the reactivation of Kaposi’s sarcoma-
associated herpesvirus (KSHV) and analyze signaling pathways activated upon this induction. We hypothe-
sized that activation of the cellular stress-activated mitogen-activated protein kinase (MAPK) p38 pathway
would play a key role in the bacterium-mediated disruption of viral latency similar to that of previously
reported results obtained with other inducers of gammaherpesvirus lytic replication. KSHV within infected
BCBL-1 cells was induced to replicate following exposure to metabolic end products from gram-negative or
-positive bacteria that were then simultaneously exposed to specific inhibitors of signal transduction pathways.
We have determined that bacterium-mediated induction of lytic KSHV infection is significantly reduced by the
inhibition of the p38 MAPK pathway. In contrast, inhibition of the phosphatidylinositol 3-kinase pathway did
not impair induction of lytic replication or p38 phosphorylation. Protein kinase C, though activated, was not
the major pathway used for bacterium-induced viral reactivation. Furthermore, hyperacetylation of histones 3
and 4 was detected. Collectively, our results show that metabolic end products from these pathogens induce
lytic replication of KSHV in BCBL-1 cells primarily via the activation of a stress-activated MAPK pathway.
Importantly, we demonstrate for the first time a mechanism by which polymicrobial bacterial infections result
in KSHV reactivation and pathogenesis.
Human herpesvirus 8 (HHV-8), also known as Kaposi’s sar-
coma-associated herpesvirus (KSHV), is a herpesvirus that has
been recognized as a significant viral pathogen, particularly for
immunocompromised persons infected with human immuno-
deficiency virus type 1 (HIV-1). KSHV belongs to a subfamily
of gammaherpesviruses (lymphotropic), together with Epstein-
Barr virus (EBV), herpesvirus saimiri, and murine gammaher-
pesvirus 68. This virus has been consistently associated with
Kaposi’s sarcoma (7), the most common neoplasm observed in
individuals infected with HIV-1. KSHV is also associated with
two lymphoproliferative diseases, multicentric Castleman’s dis-
ease (42) and primary effusion lymphoma (PEL) or body cav-
ity-based lymphoma (4). We and others have provided com-
pelling evidence that oral infection of KSHV does occur in
patents with Kaposi’s sarcoma (15, 47) and among healthy
populations (15).
A hallmark of all herpesviruses, including KSHV, is their
ability to establish life-long latent infections in their natural
host cells (40). In latent infection, the viral genome persists
extrachromosomally as a circular episome, viral gene expres-
sion is severely attenuated, and viral progeny are not produced
(12). During reactivation, KSHV-infected cells express a vari-
ety of lytic cycle genes, linear forms of the genome are pro-
duced for packaging, and viral progeny are produced, which
ultimately results in host cell lysis (33, 37, 38, 49, ). The switch
from latency to lytic viral gene expression of KSHV is crucial
for virus spread between cells and hosts and is also likely to
play an important role in the tumorigenesis induced by KSHV
(21, 33). Previous studies have demonstrated that KSHV viral
replication in PEL and Kaposi’s sarcoma tumor cells is tightly
regulated, with viral genomes persisting predominantly in a
latent state (14, 41). Although the exact mechanism by which
latent virus becomes reactivated and begins lytic replication is
not entirely known, treatment of PEL cells with chemical
agents, such as the phorbol ester phorbol-12-tetradecanoate-
13-acetate (TPA) (38), the short-chain fatty acid n-butyrate
(33), the calcium ionophore ionomycin (5), and the DNA
methyltransferase inhibitor 5-azacytidine (8), induced KSHV
replication. Other studies have also shown that inflammatory
cytokines (5), coinfection with HIV-1 (45), and hypoxic condi-
tions (11) can also directly induce lytic viral reactivation. Cer-
tain physiological conditions reactivate the latent virus period-
ically in most asymptomatic carriers, potentially leading to the
onset of disease. Such conditions include immunodeficiency
either due to AIDS or as a result of organ transplantation (16,
30).
There is a paucity of knowledge with regard to the influence
of local physiologic factors on reactivation of this and other
herpesviruses. Recent experiments from our laboratory have
shown that spent media from selected gram-negative anaerobic
bacteria (Fusobacterium nucleatum and Porphyromonas gingi-
valis), which contain lipopolysaccharides and high levels of
short-chain fatty acids, such as n-butyric, propionic, and iso-
valeric acids, can also induce the switch between latency and
lytic replication of KSHV (the present study).
Contreras et al. (9) detected a positive relationship be-
tween subgingival coinfections of herpesviruses and periodon-
tal pathogens, including P. gingivalis, F. nucleatum, and others;
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while studies by Mardirossian et al. (31) have found that hu-
man herpesviruses, including KHSV, occur at a higher fre-
quency in subgingival specimens from periodontitis. In light of
the fact that we have shown that metabolic end products from
selected gram-negative anaerobic periodontal pathogens can
induce KSHV lytic reactivation and a positive relationship
exists between herpesviruses and periodontal pathogens, it is
conceivable that bacterial infection may pave the way for in-
creased viral replication and enhanced pathogenesis of both
organisms. Understanding the molecular pathogenic mecha-
nisms that exist between viruses and bacteria that permit their
survival, propagation, and subsequent involvement in disease
development is critical for the development of more effective
diagnostic, preventative, and treatment strategies.
The current study was designed to begin to decipher these
mechanisms by focusing on the signal transduction pathways
that might allow bacterial metabolic end products from some
of the most common periodontal pathogens to modulate/reg-
ulate key molecular events in KSHV reactivation. Specific in-
hibitors for candidate signaling pathways were used to examine
the relevance of each pathway to mediate the induction of lytic
replication following exposure of a PEL cell line latently in-
fected with KSHV to the metabolic end products of common
periodontal pathogens. Results show that metabolic end prod-
ucts from these pathogens induce lytic replication of KSHV in
BCBL-1 cells primarily via activation of the stress-activated
mitogen-activated protein kinase (MAPK) pathway. Protein
kinase C (PKC), though activated, is not the major pathway
used for bacterium-induced viral reactivation.
MATERIALS AND METHODS
Cell lines and cell culture. BCBL-1 is a latently infected KSHV body cavity-
based, lymphoma-derived cell line (a gift from Blossom Domania, University of
North Carolina, Chapel Hill, NC). DG75 is a KSHV-negative B lymphoblastoid
cell line (obtained from ATCC). Cell lines were maintained in 5% CO2 at 37°C
in RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS) and
containing penicillin, streptomycin, sodium pyruvate, and L-glutamine (GIBCO-
BRL, Gaithersburg, MD). A293 human embryonic kidney cells (obtained from
ATCC) were maintained in 5% CO2 at 37°C in Dulbecco’s modified Eagle’s
medium supplemented with 10% FBS containing penicillin and streptomycin. P.
gingivalis strain A7436, F. nucleatum strain 1594, Prevotella intermedia CB21,
Streptococcus mutans 10449, and Staphylococcus aureus ATCC 25923 were kind
gifts from Roland Arnold (University of North Carolina, Chapel Hill, NC). P.
gingivalis, F. nucleatum, S. mutans, and P. intermedia were grown anaerobically in
Wilkins-Chalgren (WC) anaerobic broth (Oxoid) in an atmosphere of 5% CO2,
10% H2, and 85% N2 at 35°C (in a Coy anaerobic chamber). S. aureus was grown
aerobically in WC broth at 37°C. Spent medium was collected from cells that
were harvested from overnight culture at a late exponential stage of growth.
Antibodies and chemicals. The rabbit polyclonal antibody detecting phosphor-
ylated kinase p38 and the respective inactive nonphosphorylated form were
purchased from Cell Signaling Technology, Beverly, MA. The rabbit polyclonal
antibody against KSHV RTA was a gift from Ren Sun (University of California,
Los Angeles, CA). The goat polyclonal antibody against -actin was purchased
from Santa Cruz Biotechnology, Inc., Santa Cruz, CA. The KSHV virus-specific
monoclonal antibodies for K8.1 and LANA and polyclonal antibody for viral
interleukin 6 (vIL-6) were obtained from Advanced Biotechnologies Inc., Co-
lumbia, MD. Acetyl-histone 3 and 4 (H3 and H4, respectively) antibodies were
obtained from Upstate Biotechnology Inc., Charlottesville, VA. Sodium butyrate
(n-butyrate) and TPA were purchased from Sigma, St. Louis, MO. The phos-
phatidylinositol 3-kinase (PI3 kinase) inhibitor LY294002 [2-(4-morpholinyl)-
8-phenyl-1(4H)-benzopyran-4-one hydrochloride] was purchased from Cell
Signaling Technology, Beverly, MA. The PKC inhibitor GF109203X (bisindolyl-
maleimide I [GFX]) was purchased from EMD Biosciences, Inc., San Diego, CA.
The p38 kinase inhibitor SB202190 [4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-
pyridyl)1H-imidazole] was purchased from Sigma, St. Louis, MO, and the inhibitor
PD169316 [4-(4-fluorophenyl)-2-(4-nitrophenyl)-5-(4-pyridyl)-1H-imidazole] was
purchased from Calbiochem, San Diego, CA. RQ1 DNase was obtained from
Promega, Madison, WI. All reagents were prepared as recommended by their
suppliers. Dimethyl sulfoxide (Me2SO) was used as a vehicle for TPA and each
of the inhibitors.
Induction and treatment. Cells were maintained at densities between 2.5 
105 and 3.0  105 cells/ml. Ten milliliters of fresh growth medium was added to
the cells prior to drug treatment or exposure to spent medium. The cells were
preincubated in culture medium supplemented with kinase inhibitors (SB202190,
PD169316, GFX or LY2940020) at 10 M, 2 M, 5 M, and 10 M, respectively,
for 1 h at 37°C. Effects of all inhibitors used were not due to an increase in
cellular toxicity (data not shown). These cells were subsequently induced into the
lytic cycle by exposure to 0.3 mM sodium butyrate (NaB) or 20 ng TPA per ml.
Spent media from the anaerobic gram-negative bacteria P. gingivalis and F.
nucleatum or gram-positive bacteria S. aureus and S. mutans grown to late log
phase were centrifuged at 10,000 rpm for 20 min to remove the bacteria and
supernatants and filtered through a 0.45-micrometer-pore-size filter. The super-
natants were added at a 1:50 dilution in place of the pharmacological chemical
inducer (n-butyrate or TPA) to determine their induction capabilities. Aliquots
were collected for protein and viral DNA isolation from cells harvested at 24 to
48 h or when indicated at different time intervals postinduction. Successful
induction was determined by detection of viral lytic gene expression and virion
production.
Extracellular KSHV virion DNA isolation. BCBL-1 cells were removed from
the medium by centrifugation at 1,500  g for 5 min. The supernatant was
collected and centrifuged again for 30 min at 3,000 rpm. The cell-free culture
medium was filtered through a 0.45-micrometer-pore-size filter distributed into
Beckman Ultra Clear tubes, and viral particles were pelleted by ultracentrifuga-
tion at 22,000 rpm for 2 h at 4°C. The supernatant was removed, and viral pellets
were resuspended in buffer containing 40 mM Tris-HCl (pH 7), 10 mM NaCl, 6
mM MgCl2, and 10 mM CaCl2. RQ1 DNase was added, followed by incubation
at 37°C for 1 h to eliminate free DNA. DNase was inactivated by adding EDTA
to 20 mM and heating to 80°C for 5 min. Viral DNA was isolated using a High
Pure viral nucleic acid kit (Roche, Indianapolis, IN) and used for real-time PCR.
Conditions of infection. A293 cell monolayers were trypsinized, washed, re-
suspended in fresh culture medium, mixed with the resuspended BCBL virus or
DG75 culture medium (mock), and plated in eight-well chamber slides (Falcon)
at a concentration of 2.5  104 cells/well. At 48 h postinfection, the monolayers
were further processed for immunofluorescent antibody assay (IFA) as described
below.
Real-time PCR. Viral DNAs were employed for real-time PCR amplifications
to detect the KSHV K8.1 region of the genome. Briefly, 100 ng of DNA, SYBR
Green PCR Master Mix (Applied Biosystems, Foster City, CA), and an ABI
Prism 7000 sequence detection system were used for amplification. Primer se-
quences (Lineberger Cancer Center Nucleic Acid Core Facility, University of
North Carolina, Chapel Hill, NC) previously described by Fakhari and Dittmer
(17) were used to detect the K8.1 viral DNA. DNA from uninfected DG75 cells
and reactions run in the absence of added DNA served as negative controls.
Analyses of the data were performed with associated Prism 7000 software (Ap-
plied Biosystems). The uninduced K8.1 level was arbitrarily set at 1.
Protein preparation and electrophoresis. For extraction of total cellular pro-
tein, cells were collected by centrifugation, washed once in phosphate-buffered
saline, resuspended in 200 l ice cold extraction (RIPA) buffer (50 mM Tris-HCl
[pH 7.5], 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 0.1% sodium dodecyl
sulfate [SDS], 1% Na deoxycholate, 25 g/ml leupeptin, and 50 l protease
inhibitor cocktail [Sigma]), passed through a 25-gauge needle, and centrifuged.
For nuclear protein extraction, cell pellets were washed as described above and
resuspended in 500 l ice cold extraction buffer A (10 mM HEPES [pH 7.9], 1.5
mM MgCl2, 10 mM KCl, 1.0 mM dithiothreitol) and centrifuged. Cells were then
resuspended in 200 l buffer A containing 0.1% NP-40 and 1 complete pro-
teinase inhibitor, incubated on ice for 10 min, and centrifuged to pellet nuclei.
Nuclear pellets were washed in buffer A, centrifuged, and resuspended in 50 l
of extraction buffer C (10 mM HEPES [pH 7.9], 420 mM NaCl, 1.5 mM MgCl2,
0.2 mM EDTA, 1.0 mM dithiothreitol, 25% glycerol), incubated on ice for 30
min with occasional vortexing, and centrifuged. Cell lysates were resuspended in
SDS sample buffer, and 50 to 150 g of proteins was loaded in lanes for
SDS-polyacrylamide gel electrophoresis.
Immunoblot analysis. Immunoblot analysis was performed for the detection of
activated forms of proteins by immunoblotting with antiphospho antibodies
(phosphorylated p38). Blots were also reacted with antibodies to detect -actin
to confirm equal protein loading. Virus-specific antibodies were used to detect
the expression of viral proteins RTA, vIL-6, LANA, or K8.1 and cellular acety-
lated histone 3 or 4. The proteins were transferred overnight onto polyvinylidene
difluoride membranes (Millipore), and immunocytochemistry protocols for each
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FIG. 1. (A) Increased virion release induced by spent media from periodontopathic bacteria. BCBL-1 cells were treated with or without spent
media from P. gingivalis, F. nucleatum, P. intermedia, and S. mutans and NaB or TPA (positive controls). The level of viral DNA was quantified
using real-time PCR to amplify the K8.1 region of the viral genome 24 h after treatment. (B) Productive infection of A293 cells by KSHV virions
isolated following induction by spent medium from selected periodontopathic bacteria. A293 cell monolayers were fixed and incubated with
antibodies against glycoprotein K8.1 or RTA at 48 h postinfection with virus isolated from TPA or n-butyrate (positive controls) or spent media
from gram-negative or -positive bacteria. Virus isolated from WC (uninduced) medium was used as a negative control. Secondary monoclonal or
polyclonal antibodies conjugated to Alex Flour 488 (green) or Alex Fluor 546 (red), respectively, were used to detect the primary antibody bound
to KSHV antigens, and DAPI stain was used to detect the cell nuclei. The fluorescein isothiocyanate (FITC) column shows the Alex Flour 488
channel (K8.1 or LANA), the rhodamine column shows the Alex Fluor 546 channel (RTA), and the merge column shows the Alex Flour 488 and
Alex Fluor 546 overlay (K8.1/RTA). (C) Effect of spent media from periodontopathic bacteria on the induction of immediate early, early, and late
lytic KSHV gene expression. BCBL-1 cells were treated with or without TPA or sodium butyrate (NaB) (positive controls) or spent media from
P. gingivalis, F. nucleatum, or S. aureus. Whole cellular protein was extracted and run on a 10% SDS-polyacrylamide gel. The expression of
immediate early (RTA), early lytic (vIL-6), late lytic (K8.1), and latent (LANA) as well as the cellular -actin protein was examined by immunoblot
analysis using anti-RTA, anti-vIL-6, anti-K8.1, anti-LANA, and anti--actin antibodies, respectively. (D) Expression of early and late lytic KSHV
genes following induction by active spent media. Immunofluorescence confocal microscopic detection of KSHV antigens. KSHV latently infected
BCBL-1 cell monolayers were fixed and incubated with antibodies against glycoprotein K8.1, RTA, and LANA at 24 h postinduction with TPA,
n-butyrate (positive controls), or spent media from gram-negative or -positive bacteria. Uninfected DG75 cells were used as negative controls.
Secondary monoclonal or polyclonal antibodies conjugated to Alex Flour 488 (green) or Alex Fluor 546 (red), respectively, were used to detect
the primary antibody bound to KSHV antigens, and DAPI stain was used to detect the cell nuclei. The FITC columns show the Alex Flour 488
channel (K8.1 or LANA), the rhodamine column shows the Alex Fluor 546 channel (RTA), and the merge column shows the Alex Flour 488 and
Alex Fluor 546 overlay (K8.1/RTA).
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specific antibody were followed as instructed by the manufacturer. Immunore-
active bands were visualized with SuperSignal West Pico chemiluminescence
substrate (Pierce) according to the manufacturer’s instructions. The relative level
of expression of each cellular or viral protein was determined by quantitative
densitometry. The increase (n-fold) over that expressed in the uninduced state
was calculated.
IFA. The detection of KSHV antigens in infected cells was performed as
previously described (15). Briefly, cells were fixed in 1:1 methanol-acetone,
washed in PBS, and blocked overnight at 4°C with 20% normal goat serum in
PBS. Cells were incubated overnight at 4°C with primary antibodies diluted in
20% normal goat serum, as follows: a mouse monoclonal antibody against the
lytic infection-associated viral glycoprotein K8.1, a rabbit polyclonal antibody
against the viral RTA, a rat monoclonal antibody against KSHV LANA, and
rabbit polyclonal antibodies against histone 3 or 4 (Upstate Biotechnology, Inc.,
Charlottesville, VA.). Last, cells were washed, stained with goat anti-mouse
secondary antibody conjugated to Alex Fluor 488 (K8.1), goat anti-rat secondary
antibody (LANA) conjugated to Alex Fluor 488 or goat anti-rabbit secondary
antibody (gB) (acetylated histone 3 or 4) conjugated to Alex Fluor 546 (Molec-
ular Probes, Inc.) for 1 h at an ambient temperature. Slides were washed with
PBS, then mounted and coverslipped using Vectoshield containing 4,6-di-
amidino-2-phenylindole (DAPI), and analyzed by confocal microscopy using a
Zeiss LSM Pascal microscope.
RESULTS
Anaerobic bacterium spent media induce the KSHV lytic
cycle. Because of the increase in viral production in the setting
of periodontal disease, we examined the potential for meta-
bolic end products in the bacterial spent media to induce virus
production and secretion. In order to quantify the level of viral
DNA subsequent to bacterial induction, real-time PCR was
employed to amplify the K8.1 region of the viral genome from
the culture medium of uninduced control BCBL-1 cells and
BCBL-1 cells incubated with the pharmacologic inducer n-
butyrate or TPA or spent media from P. gingivalis, F. nuclea-
tum, P. intermedia, and S. mutans. In replicate experiments, we
detected a 4.5- to 6-fold increased production over that of
uninduced cells in the amplification of the DNase-resistant
K8.1 region of KSHV virion DNA release from cells treated
with spent media from P. gingivalis and F. nucleatum but not
medium from P. intermedia or S. mutans (Fig. 1A). Significant
amplification was also seen in cells treated with the pharma-
cological inducers n-butyrate and TPA (positive controls).
Each of these experiments was performed in triplicate. Virion
production was confirmed by the infection of A293T cells with
supernatant-derived virus from BCBL-1 cells treated with the
metabolic end products of P. gingivalis and F. nucleatum. These
infections were primarily lytic in nature, simultaneously ex-
pressing RTA and K8.1, similar to that of NaB- and TPA-
treated cells. LANA was also detected in infected cells but was
not detected in mock infection (Fig. 1B). We have also deter-
mined by immunoblotting that spent media from P. gingivalis
and F. nucleatum induced expression of the immediate early
protein ORF50, the early protein vIL-6, and the late lytic
protein K8.1 to levels comparable to that of the known phar-
macologic inducers TPA and n-butyrate (Fig. 1C.). LANA
protein levels remained constant upon induction and were
comparable to LANA levels in uninduced and gram-positive
medium-treated cells (Fig. 1C). We have also determined,
using real-time PCR, that these anaerobic spent media are also
FIG. 1—Continued.
VOL. 81, 2007 BACTERIUM-INDUCED VIRAL REACTIVATION 6035
capable of EBV lytic induction (data not shown). These results
were confirmed by simultaneous immunofluorescent detection
of RTA and K8.1 by confocal analysis upon incubation of
BCBL-1 cells with spent media from the gram-negative anaer-
obes P. gingivalis and F. nucleatum or with the pharmacologic
inducer n-butyrate or TPA. Spent medium from the gram-
positive organism S. aureus did not result in expression of K8.1
(Fig. 1D, lanes 3 to 6), although minimal expression of RTA
was observed. Accordingly, nuclear expression of LANA was
detected irrespective of treatment (Fig. 1D, lanes 1 and 2). No
signal was detected from DG75 negative control cells for all
treatments. Together, these results suggest that metabolic end
products in the spent media from the gram-negative anaerobic
bacteria P. gingivalis and F. nucleatum, but not P. intermedia, S.
mutans (Fig. 1A), or S. aureus (Fig. 1B to D), are capable of
inducing KSHV viral reactivation, inducing the KSHV tempo-
ral cascade and production of infectious virus.
PKC inhibition blocks KSHV induction by TPA, but not by
n-butyrate or spent media of P. gingivalis and F. nucleatum. To
establish the role of PKC in KSHV lytic reactivation, we in-
vestigated the effect of a PKC inhibitor in PEL-derived KSHV-
infected BCBL-1 cells by using Western blotting with an anti-
body specific for vIL-6. Cell cultures were treated with the
PKC inhibitor GFX 1 h prior to induction with TPA, n-bu-
tyrate, or bacterial spent media. The cells were harvested 24 h
postinduction. As demonstrated by virion detection, we con-
sistently obtained KSHV lytic reactivation in cultures treated
with TPA, n-butyrate, F. nucleatum, and P. gingivalis but not in
uninduced cultures in the absence of GFX. Reactivation was
confirmed by measuring the level of early lytic protein vIL-6
expression by Western blotting analysis (Fig. 2A and B). When
5 M GFX, which inhibits the PKC , , , , and ε isoforms
(24), was added, virus reactivation was largely inhibited in the
TPA-treated culture (Fig. 2A) but not in the cultures treated
with n-butyrate, F. nucleatum or P. gingivalis (Fig. 2B). Results
are representative of at least two experiments. These results
suggest that KSHV reactivation by TPA depends to a large
extent on the activity of one or more isoforms of PKC, similar
to that observed by Deutsch et. al. (13). On the other hand, the
PKC pathway does not appear to be important for n-butyrate
or bacterial metabolic end-product-mediated viral reactiva-
tion.
Inhibitors of p38, but not PI3 kinase pathway, inhibit KSHV
lytic reactivation. Previous reports suggested that the PI3 ki-
nase pathway is required for KSHV entry into target cells,
while the stress-activated p38 MAPK pathway is minimally
involved (34, 48). To determine whether the PI3 kinase and
p38 kinase pathways were critical during bacterium-mediated
viral reactivation from latency, BCBL-1 cells were preincu-
bated for 1 h with the PI3 kinase inhibitor LY294002 prior to
induction with spent medium from P. gingivalis or S. aureus.
Treatment with spent medium from S. aureus did not result in
activation, while treatment with spent medium from P. gingi-
valis did induce replication (Fig. 3, lanes 1 and 2). -Actin was
used as a loading control. Viral reactivation was measured by
detection of early lytic anti-vIL-6 by Western blotting analysis.
Results are representative of at least two experiments. Two
distinct exposures are shown, each reflecting a similar trend.
vIL-6 expression increased and remained largely unchanged in
the presence of the PI3 kinase inhibitor (Fig. 3, lane 2). In
contrast, the p38 inhibitors SB202190 and PD169316 abolished
vIL-6 expression (Fig. 3, lanes 3 and 4). These results clearly
demonstrate that the PI3 kinase pathway is not important for
induction mediated by metabolic end products of gram-nega-
tive anaerobic bacteria. The p38 pathway, however, appears to
be critical for expression of the early viral lytic gene and might
therefore function as a potential upstream mediator of vIL-6
expression. Spent medium from S. aureus failed to increase
vIL-6 expression. Accordingly, inhibition of the catalytic activ-
ity of the phosphorylated form of p38 kinase precluded viral
reactivation, as shown by the decrease in detection of K8.1
expression upon treatment with the p38 inhibitor SB202190.
This reduction was most dramatic at 24 h posttreatment (Fig.
3B).
Phosphorylation-specific antibodies were used to examine
the phosphorylation state of p38 MAPK upon treatment with
bacterial spent media. Figure 3 shows a significant increase in
the phosphorylation state upon induction with P. gingivalis.
Phosphorylation of p38 MAPK was also observed in the pres-
ence of the PI3 kinase and p38 inhibitors; however, a signifi-
cant decrease in the expression of vIL-6 and K8.1 was observed
only in the presence of the p38 kinase inhibitors (Fig. 3A, lanes
3 and 4, and Fig. 3B, lanes 3 and 5, respectively). Hence, p38
appears to be phosphorylated, resulting in viral reactivation
independent of PI3 kinase activation (Fig. 3A, lane 2). In
contrast, inhibition of the catalytic activity of the activated
(phosphorylated) form of p38 kinase precluded viral reactiva-
tion, as shown by a decrease in the expression of early lytic
vIL-6 and late lytic K8.1 (Fig. 3A, lanes 3 and 4, and Fig. 3B,
lanes 3 and 5). This is consistent with the known function of the
inhibitors SB202190 and PD169316 to allow phosphorylation
(activation) but inhibit the catalytic activity of p38 MAPK.
Total p38 was consistently detected regardless of treatment.
Spent media from gram-negative anaerobic bacteria inhibit
histone deacetylase activity, resulting in hyperacetylation of
histones. Several studies have shown that butyrate inhibits
histone deacetylase (HDAC) activity and promotes hyper-
acetylation of histones, leading to the regulation of gene ex-
pression (1, 3, 10, 43, 46). Furthermore, activation of both the
extracellular signal-regulated kinase (ERK) and the p38
MAPK signaling pathways has been tied to a global increase
in H3 acetylation and phosphorylation (28). Inhibition of
FIG. 2. Effect of PKC inhibition on the induction of early lytic
KSHV gene expression. BCBL-1 cells were treated with or without
(Un) TPA (positive control) (A) or spent medium from P. gingivalis
(PG), F. nucleatum (FN), or NaB (negative control) (B) and the PKC
inhibitor (GFX). The expression of early lytic (vIL-6) as well as the
cellular -actin protein was examined by immunoblot analysis.
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deacetylation leads to hyperacetylation of histones, and n-bu-
tyrate has been shown to increase the level of acetylated his-
tones (39). To directly test the effects of the spent media on
histone 3 and histone 4 acetylation levels, whole-cell protein
extracts from BCBL-1 cells cultured in the presence of spent
medium from P. gingivalis were examined by Western blotting
analysis using antibodies specific for acetylated histone 3 or
histone 4. Cells were cultured in the presence of n-butyrate, a
known promoter of histone 3 hyperacetylation (positive con-
trol), TPA, a phorbol ester known to not have HDAC inhibi-
FIG. 3. (A) Effect of p38 and PI3K inhibition on the induction of early lytic KSHV gene expression. BCBL-1 cells were pretreated with the PI3
kinase (LY294002) or p38 (SB202190 and PD169316) inhibitors for 1 h at 37°C and then treated with spent medium from S. aureus or P. gingivalis
for 24 or 48 h. The expression of early lytic (vIL-6), phospho-p38 (p	p38), total p38, and cellular -actin proteins was examined by immunoblot
analysis. PD, PD169316; SB, SB202190; LY, LY294002; PG, P. gingivalis; SA, S. aureus. (B) Effect of p38 inhibition on the induction of late lytic
KSHV gene expression. BCBL-1 cells were pretreated with the p38 inhibitor (SB202190) for 1 h at 37°C and induced with spent media from P.
gingivalis (PG) and F. nucleatum (FN). The expression of late lytic (K8.1) and cellular -actin proteins was examined by immunoblot analysis using
anti-K8.1 and anti--actin antibodies.
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tion activity (negative control), or spent medium from P. gin-
givalis, F. nucleatum, or S. aureus for 24 h. Equal amounts of
lysate were immunoblotted with antibodies specific for acetyl
H3 and acetyl H4 (Fig. 4A). Results are representative of at
least two experiments. As expected, acetylation of both histone
3 and histone 4 significantly increased when the cells were
cultured in the presence of the P. gingivalis and F. nucleatum
spent media and n-butyrate (Fig. 4A, lanes 2 and 4). No effect
was observed for the uninduced cells or for cells induced with
TPA (Fig. 4A, lanes 1 and 3). A much milder effect was de-
tected upon treatment with S. aureus. Furthermore, we have
demonstrated H3 and H4 hyperacetylation in P. gingivalis-, F.
nucleatum-, and NaB-treated cells by IFA. Acetylated histones
3 and 4 were detected in the nuclei of treated BCBL-1 cells,
while those cells treated with TPA, S. aureus, or WC broth did
not demonstrate expression of hyperacetylated H3 or H4 (Fig.
4B). These results clearly demonstrate the presence of H3 and
H4 that is modified by acetylation and is dependent on expo-
sure of the cells to n-butyrate, F. nucleatum, or P. gingivalis
metabolic end products. Minimal acetylation was observed for
DG75 cells treated with spent medium from P. gingivalis or S.
aureus.
Inhibition of p38 kinase blocks hyperacetylation of histone
3. The determination that p38 kinase phosphorylation is in-
duced by the gram-negative anaerobic bacterial spent media
led us to examine the role of p38 kinase in mediating H3
acetylation. BCBL-1 cells were pretreated with the p38 kinase
inhibitor SB202190 for 1 h and then induced with spent me-
dium from P. gingivalis or F. nucleatum. Protein extracts were
examined by Western blotting analysis using antibodies specific
for acetylated histone 3 and vIL-6. As shown in Fig. 5, lanes 2
and 4, both the hyperacetylation of H3 and the KSHV reacti-
vation (vIL-6 expression) were induced by treatment with the
gram-negative spent media from P. gingivalis and F. nucleatum
and blocked by the inhibition of p38 (Fig. 5, lanes 3 and 5).
This result implies that activation of the p38 kinase signaling
pathway mediates spent-medium-induced hyperacetylation of
H3. This correlates well with vIL-6 expression and suggests
that p38 kinase activation and H3 acetylation might be crucial
upstream events required for viral reactivation. In addition, the
presence of hyperacetylated H3 as early as 1 h postinduction
(Fig. 6, lane 2) suggests that p38 is activated, resulting in
hyperacetylation of H3 prior to de novo expression of early and
late viral gene products. Results are representative of at least
two experiments.
DISCUSSION
The data presented in this study support our hypothesis that
metabolic end products of the gram-negative anaerobic peri-
odontopathogens F. nucleatum and P. gingivalis can efficiently
reactivate KSHV lytic replication using stress-activated path-
ways, resulting in an increase in the release of virions, similar
to that of physiological concentrations (0.3 mM) of the phar-
macologic inducer n-butyrate. In contrast, S. aureus and S.
mutans, gram-positive organisms with distinctly different end
products, did not result in activation of these pathways or in
viral reactivation. This hypothesis was plausible since both of
these organisms produce high levels of butyric acid (26), a
major by-product of anaerobic metabolism, which can be de-
tected in gingival fluid from periodontal pockets (2). Nieder-
man et al. (35) report severely diseased subjects exhibited

10-fold increases in the concentrations of this short-chain
fatty acid compared to that of mildly diseased subjects (where
the mean severe butyric acid concentration was 2.6  0.4 mM,
and the mean mild concentration was 0.2  0.04 mM). There-
fore, it is possible that this short-chain fatty acid and others
(e.g., propionic acid), in addition to yet-unidentified factors
within the crude media, might play a contributory role in the
initiation and/or perpetuation of KSHV reactivation and
pathogenesis. Furthermore, P. intermedia, a gram-negative
anaerobe which does not secrete these short-chain fatty acids
and has a lipopolysaccharide (LPS) that is structurally similar
to that of P. gingivalis, does not result in significant reactivation
FIG. 4. (A) Hyperacetylation of histones 3 and 4 following induc-
tion by bacterial spent media. Nuclear protein was extracted from
BCBL-1 cells left untreated (Un) or cultured in the presence of spent
medium from P. gingivalis (PG) or NaB (positive control) for 24 h and
run on an 18% SDS-polyacrylamide gel. Equal amounts of lysate were
immunoblotted with anti-acetyl H3 or H4 antibodies. Fn, F. nucleatum;
Sa, S. aureus. (B) Immunofluorescence detection of hyperacetylated
histones 3 and 4 following induction by bacterial spent medium. Im-
munofluorescence confocal microscopy was used to detect acetylated
histones 3 and 4 in latently infected KSHV BCBL-1 and uninfected
DG75 cells 24 h postinduction with spent medium from gram-negative
or -positive bacteria or TPA and n-butyrate. Uninduced BCBL-1 cells
served as negative controls. Secondary polyclonal antibodies conju-
gated to Alex Fluor 546 (red) were used to detect the primary antibody
bound to the acetylated histones, and DAPI stain was used to detect
the cell nuclei. The rhodamine column shows the Alex Fluor 546
channel (acetyl-histone 3 or 4). PG, P. gingivalis; FN, F. nucleatum; SA,
S. aureus.
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and productive infection. (Fig. 1A). It may therefore be rea-
sonable to hypothesize that LPS may not be the primary factor
responsible for viral reactivation in our system. Despite the
impressive array of evidence implicating PKC in the switch
between latency and reactivation of the gammaherpesviruses
EBV and KSHV (13, 18, 51), our studies have shown that
although PKC may mediate KSHV lytic reactivation after TPA
stimulation (Fig. 2A), bacterium-induced viral reactivation,
like that by n-butyrate, proceeds by a PKC-independent mech-
anism as determined by GFX failure to block lytic-cycle induc-
tion. (Fig. 2B). Similar results by Gradoville et al. (20) have
been demonstrated for certain latently infected EBV cell lines.
They have shown that activation of PKC is not an obligatory
event for the switch between latency and lytic-cycle gene ex-
pression of EBV in HH514-16, FF41, and W91 cells. In addi-
tion, lytic-cycle induction by HDAC inhibitors (e.g., n-butyrate
and trichostatin A) proceeded by a PKC-independent mecha-
nism in HH514-16 and FF41 cells (20), similar to that shown
for BCBL-1 cells infected with KSHV in our studies. It there-
fore appears that although the TPA-induced PKC signaling
pathway might mediate viral reactivation, a separate signaling
pathway independent of PKC activation is primarily used for
bacterium-induced reactivation and histone deacetylase inhib-
itors. Finally, Yu et al. (49) have demonstrated that n-butyrate
is much more effective than the phorbol ester TPA in inducing
high levels of KSHV class II and III virus transcription and
viral DNA replication. This would suggest that although the
gram-negative anaerobes also produce LPS, which acts as a
PKC activator, activation of an alternate pathway induced by
FIG. 5. Effect of p38 inhibition on the hyperacetylation of H3 and induction of late KSHV gene expression. Whole-cell protein was extracted
from BCBL-1 cells pretreated with the p38 inhibitor (SB202190) for 1 h at 37°C and induced with spent media from P. gingivalis (PG) and F.
nucleatum (FN). Extracts were run on an 18% SDS-polyacrylamide gel. The expression of early lytic vIL-6, the acetylation status of H3, and the
cellular -actin protein were examined by immunoblot analysis using anti-vIL-6, anti-acetyl H3, and anti--actin antibodies, respectively. SB,
SB202190.
FIG. 6. Effect of P. gingivalis (Pg) on H3 acetylation. BCBL-1 cells
were induced with spent medium from P. gingivalis. Cellular lysate was
collected at the times indicated, and the acetylation status of H3, as
well as the cellular -actin protein, was examined by immunoblot
analysis using anti-acetyl H3 and anti--actin antibodies. UN, un-
treated.
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n-butyrate and the spent media overrides the LPS-induced
PKC pathway. One possible explanation for this observation
might be that the KSHV K1 protein, the expression of which is
significantly induced during the lytic phase of the viral life
cycle, suppresses TPA-mediated (and therefore, LPS-medi-
ated) KSHV reactivation (27). Alternatively, Jung et al. (23)
have shown that HDAC inhibitors can prevent TPA-induced
responses via modulation of MAP kinases; therefore, it is pos-
sible that bacterial metabolites/n-butyrate could suppress the
TPA-induced response in our system by a similar mechanism.
Activation of PKC, however, may play a yet-unexplored sec-
ondary role.
To explore other candidate signaling pathways potentially
activated during viral reactivation by the bacterial spent media,
specific inhibitors of the PI3 and p38 kinase pathways were
used. Our data showed that lytic reactivation was blocked in
the presence of the p38 kinase inhibitors yet persisted in the
presence of the PI3 kinase inhibitor (Fig. 3). Interestingly,
upon bacterium-induced reactivation, Akt phosphorylation
also increased over 48 h, even in the presence of the PI3 kinase
inhibitor (data not shown). It is possible that Akt is phosphor-
ylated in a PI3 kinase-independent manner. Activation of
Ca2/calmodulin-dependent protein kinases (36) or an as-yet-
unidentified cellular or viral kinase may result in this modifi-
cation upon bacterium-induced reactivation.
Activation of p38 MAPK signaling pathways results in a
global increase in coupled histone H3 phosphorylation (Ser-
10) and acetylation (Lys-14) (H3 phosphoacetylation) and H4
acetylation via MSK1 (28). Studies have shown that HDAC
inhibitors can induce phosphorylation of H3, thus facilitating
acetylation (1, 3, 39, 43, 46), and this phosphorylation can be
blocked by p38 inhibition (50). Observations by Lu et al. (29)
have demonstrated that the HDAC inhibitor n-butyrate in-
duces H3 and H4 hyperacetylation at ORF50, encoding the
immediate early protein KSHV RTA, resulting in the initiation
of KSHV lytic-cycle replication. Similar studies have shown
that HDAC-induced acetylation of histones activates the tran-
scription of the Epstein-Barr virus lytic gene BRLF1 (6).
P. gingivalis and F. nucleatum, two common oral pathogens
associated with human periodontitis (44) and potent activators
of viral reactivation, release the short-chain fatty acid (bu-
tyrate) as one of the major by-products into the microenviron-
ment (19), along with other volatile fatty acids (25). Moreover,
histone hyperacetylation in T cells has been reported following
the exposure of T cells to culture supernatants of P. gingivalis
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FIG. 7. Model for induction of KSHV reactivation by metabolic end products from gram-negative bacteria, which contain high levels of butyric
acid, inhibit cellular HDACs, and activate the p38 kinase pathway. Activation of the p38 pathway may lead to phosphorylation of cellular histones,
which results in increased sensitivity to acetylation by histone acetyltransferases. The combined effects of HDAC inhibition and increased
acetylation sensitivity result in hyperacetylation of the histones on immediate early viral promoters. The acetylation event neutralizes the positive
charge of the histone tail and remodels chromatin structure, making the nucleosome accessible for binding to transcription factors and activation
of the temporal cascade of viral gene expression and subsequent viral production. Viral genes are denoted as E (early), IE (immediate early), and
L (late). MEK, mitogen-activated protein kinase/extracellular signal-regulated protein kinase kinase; SB, SB202190; PD, PD169316.
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supernatants from P. gingivalis and F. nucleatum inhibit HDACs
in a fashion similar to butyrate and other histone deacetylase
inhibitors and that this process is associated with an increase in
the levels of histone 3 and 4 acetylation (Fig. 4, 5, and 6).
Consistent with the notion that the pathway utilized for TPA-
induced viral reactivation is distinct from that used for anaer-
obic spent media and n-butyrate-induced reactivation, TPA
induces KSHV reactivation through PKC (Fig. 2A), which did
not result in acetylation of either histone. (Fig. 4). These re-
sults imply that upon bacterium-mediated viral induction,
modification of cellular histones 3 and 4 occurs as a result of
HDAC inhibition. Bacterium-induced H3 acetylation is an
early event, detectable after 1 h posttreatment with spent me-
dia in significant advance of de novo viral protein synthesis
(Fig. 6). It would therefore seem reasonable to suggest that
acetylation of H3 and/or H4 induced by culture supernatants
from P. gingivalis and F. nucleatum might potentially play a
critical role in chromatin remodeling and subsequent regula-
tion of cellular and/or viral gene expression.
Our current study has shown that spent-medium-induced
hyperacetylation of H3 and viral reactivation are mediated by
p38 kinase. p38 kinase phosphorylation and H3 acetylation are
induced by gram-negative anaerobic bacterial spent media and
are correlated with viral reactivation. p38 pathway usage was
verified by using p38-specific inhibitors prior to induction. In
the presence of the inhibitors, H3 acetylation was significantly
diminished following induction by the gram-negative anaerobic
bacterial spent media as well as viral reactivation.
In summary, we have identified a novel mechanism for
KSHV reactivation and important signaling pathways triggered
during the reactivation process (Fig. 7). We have shown for the
first time that p38 is important to KSHV reactivation and that
p38 kinase activation and H3 acetylation might be crucial up-
stream events for bacterium-induced reactivation of lytic rep-
lication. Bacterium-virus interactions in the oral cavity, gut,
and genitourinary tract might be key to viral reactivation in
these settings. Deciphering the mechanism of bacterium-in-
duced viral reactivation has important implications for devel-
oping effective therapeutic measures to control these polymi-
crobial infections in vivo.
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